Candela Gets Lift From Robust Economy, Demand For Aesthetic Procedures
This article was originally published in The Gray Sheet
Executive Summary
Candela's stock price benefited from three related trends in 1999 - the increased acceptance of the company's flagship aesthetic lasers by physicians, an aging baby boom population willing to pay out-of-pocket for cosmetic surgical procedures, and a booming economy that has made prospective patients feel affluent enough not to give the expense a second thought.
You may also be interested in...
Cytyc ThinPrep Pap Test Distribution Helps Boost Stock 137% In 1999
Increasing availability of Cytyc's ThinPrep Pap test product through added laboratory contracts, coupled with an improved reimbursement environment and strong fundamentals, set the stage for a 137.1% run up of the cervical cytology firm's stock in 1999. The issue closed at 61-1/16, up 35-5/16 for the year.
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.